[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$ucbjy Graphic $ucbjy

$UCBJY sees increased mentions and creator activity, with positive sentiment around clinical trial developments. Engagements are up significantly, indicating growing interest in the ticker.

About $ucbjy

A cryptocurrency or stock ticker symbol.

Insights #

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +723%
1 Month: XXXXX +28%
1-Year High: XXXXX on 2025-04-29
1-Year Low: X on 2025-05-10

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +33%
1 Month: XX +38%
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-04-27

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ucbjy in the last XX hours which is no change from in the previous XX hours Daily Average: X
1 Week: X no change
1 Month: X +50%
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-04-27

Top assets mentioned In the posts about $ucbjy in the last XX hours

Johnson & Johnson (JNJ) Oruka Therapeutics, Inc. Common Stock (ORKA) AbbVie Inc (ABBV)

Top topics mentioned In the posts about $ucbjy in the last XX hours

$orkas, $jnj, $orka, $abbv, $wcrs, $tyhoy, $trrvf, $tmxxf, $thrd, $mrns, $vrdn, $cmrx, $prme

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"H.C. Wainwright reit'd $ORKA Buy/$45 after Oruka📰that the FDA had cleared its IND application for its Phase 2a trial of ORKA-001 (the company's long-acting anti-IL-23p19 antibody) in moderate-to-severe PsO called EVERLAST-A. $ABBV $PTGX - $JNJ #EDAV25 H.C. Wainwright said in its note: "This program is a randomized double-blind placebo-controlled Phase 2a trial designed to evaluate the safety and efficacy of a single dose level of ORKA-001 in moderate-to-severe psoriasis patients. EVERLAST-A will enroll approximately XX patients randomized 3:1 to receive ORKA-001 or matching placebo. The"
@Quantumup1 on X 2025-07-23 18:20:33 UTC 3534 followers, 1266 engagements

"💰 $AACAY $AMIGY $BCKIY $BIRDF $CAIXY $CLST $COST $CPHRF $CQP $DELKY $DLMAF $EFSG $ESYJY $FMS $GATX $GBOOY $GVDNY $JBTC $JINFF $MCCRF $MITFY $MLLGF $MQBKY $MTYFF $PRMRF $PSYTF $PUGBY $RDWR $RECT $RLGT $SEKEY $SPE $TCYSF $TMXXF $TRRVF $TYHOY $UCBJY $WCRS Like 😎 🙏 #Unus"
@JimyTuits on X 2025-07-23 14:05:00 UTC XXX followers, XX engagements